Tests CKD-202A, a sacubitril and valsartan combination, for high blood pressure
Tests CKD-202A against valsartan in adults with essential hypertension, high blood pressure.
Plain-language title generated from the registry record
Registry title: Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A
Key facts
- Where
- Wŏnju, South KoreaSee the site
- Phase
- Phase 3
Where in South Korea
- Wonju Severance Christian HospitalWŏnju, South KoreaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Chong Kun Dang Pharmaceutical
- Trial code
- NCT06643819
- Record updated
- 11 December 2025
- Original description
Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A(Sacubitril∙Valsartan)Read full original descriptionShow less
A Randomized, Double-blind, Active-controlled, Multi-center, Therapeutic Confirmatory, Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A
Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A(Sacubitril∙Valsartan)
Inclusion: Participants who are 19 years old or older; Participants who have voluntarily decided to participate in this clinical trial and signed ICF.
Exclusion: Participants who require combination administration of antihypertensive drugs other than clinical trial drugs during the clinical trial participation period; Participants who treated other clinical trial drugs within 4 weeks of screening visit; Pregnant women, lactating women, or Subjects who do not agree to use appropriate contraception during the clinical trial period and for two weeks after the end of administration of the last clinical trial drug; Participants with a history of secondary hypertension or suspected secondary hypertension; Participants with type 1 diabetes or poorly controlled diabetes; Participants with a history of drug or alcohol abuse or suspected patient within 24 weeks as of the time of screening; Participants with a orthostatic hypotension; Participants who are unable to participate in this clinical trial at the discretion of the investigator.